Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus.
about
Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseasesChanges in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot studyRole of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsiaScavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseCaloric restriction, aerobic exercise training and soluble lectin-like oxidized LDL receptor-1 levels in overweight and obese post-menopausal women.CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzymeSchizophrenia gene expression profile reverted to normal levels by antipsychoticsIncreased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.Low CD36 and LOX-1 Levels and CD36 Gene Subexpression Are Associated with Metabolic Dysregulation in Older Individuals with Abdominal Obesity.LOX-1 and obesity.Oxidized LDL, LOX-1 and atherosclerosis.LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.Plasma sLOX-1 is a potent biomarker of clinical remission and disease activity in patients with seropositive RA.LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus.The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular DiseaseIncreased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome.
P2860
Q26830278-00F01ADE-293C-40FA-985E-3132E152B3AEQ33851618-37FD81FD-4346-4DDA-9E99-C6274866C84CQ33944749-E38727B9-A129-40F7-88EA-4D6B279F8E85Q34218552-14433A08-EF68-4285-8DA1-6B8827EE9B4CQ34504642-0A93C9DD-8288-4818-BB08-850D766807C5Q34769808-C6D86F7E-FC96-40CD-B113-C051AA73E69EQ35179019-7F5DAA26-7966-4141-91F2-68F51CF6F1B6Q35843064-14C2BB8E-E1CF-4F83-A0C6-A6612026BF2AQ37156897-107116AD-9C10-494E-95A5-3842CBBB9810Q37924630-BCAEA7B0-916E-477B-B42E-EE78671BD3CFQ37938848-7342371E-DF14-4B18-9DF3-9297B8C99BB6Q37945097-F5A93652-219C-4312-AC7F-DDE2F78D1C01Q38025997-2B1A7E4A-822E-421F-A0D9-F7D8C07201B5Q38589168-AB9F6338-B6C6-42E0-A45F-78E000A7A20DQ39971425-F09DB432-B940-4238-91D2-0CF4124E2BE6Q41462308-B5711F32-C27D-41B7-8B41-C9149905A05DQ42011629-631D239B-F642-4286-9699-52647022CDEAQ48274755-B31BE3FF-D4F7-4386-97EC-2040B5331CECQ51349361-D15EFA47-1F4F-437C-95B0-AF2A62EB4AA4
P2860
Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@en
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@nl
type
label
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@en
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@nl
prefLabel
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@en
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@nl
P2093
P2860
P1476
Soluble lectin-like oxidized l ...... 1 in type 2 diabetes mellitus.
@en
P2093
Kathryn C B Tan
Richard Bucala
Sammy W M Shiu
P2860
P304
P356
10.1194/JLR.M700551-JLR200
P577
2008-04-12T00:00:00Z